Pfizer has big growth projections post-Upjohn. But can it actually get there?

29th October 2019 Uncategorised 0

Pfizer is reshaping itself to focus on innovative drugs and that effort will allow it to turn in strong growth for years, execs said Tuesday. The drugmaker predicts it’ll generate 6% annual revenue growth over the next five years, outperforming most of the pharmaceutical industry.

More: Pfizer has big growth projections post-Upjohn. But can it actually get there?
Source: fierce